BusinessRespireRx Pharmaceuticals Inc. to Present at 10th Annual Biotech Showcase™ 2018By Nasdaq OMXJan 8, 2018, 1:45 PM UTC
BusinessRespireRx Pharmaceuticals Inc. Officers and Directors Elect to Forgive $2,356,733 of Past Due Cash Compensation and Receive Non-Qualified Stock Options to Reduce Balance Sheet DebtBy Nasdaq OMXDec 15, 2017, 2:00 PM UTC
